DACRA
Pharmaceutical drugs for the treatment of metabolic disorders, namely, obesity, comorbidities secondary to obesity, metabolic syndrome, and related metabolic diseases; Pharmaceutical drugs for the treatment of joint disorders and osteoarthritis
Registered · April 15, 2024 · 98500219 ·